BioCorRx Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioCorRx Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • BioCorRx Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.66M, a 72.6% decline year-over-year.
  • BioCorRx Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$4.82M, a 16.1% decline year-over-year.
  • BioCorRx Inc. annual Operating Income (Loss) for 2023 was -$3.79M, a 19.4% increase from 2022.
  • BioCorRx Inc. annual Operating Income (Loss) for 2022 was -$4.7M, a 14.7% increase from 2021.
  • BioCorRx Inc. annual Operating Income (Loss) for 2021 was -$5.51M, a 26.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.